Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure

Benzodiazepine ligands of differing efficacy including the agonist, diazepam, the partial agonist, Ro 16–6028 and the antagonist, Ro 15–1788, were administered in vivo to rats continuously for 3 weeks. The magnitude of change in various measures of GABA sensitivity could be correlated directly with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1989-11, Vol.170 (3), p.145-155
Hauptverfasser: Hernandez, Theresa D., Heninger, Catherine, Wilson, Marlene A., Gallager, Dorothy W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 155
container_issue 3
container_start_page 145
container_title European journal of pharmacology
container_volume 170
creator Hernandez, Theresa D.
Heninger, Catherine
Wilson, Marlene A.
Gallager, Dorothy W.
description Benzodiazepine ligands of differing efficacy including the agonist, diazepam, the partial agonist, Ro 16–6028 and the antagonist, Ro 15–1788, were administered in vivo to rats continuously for 3 weeks. The magnitude of change in various measures of GABA sensitivity could be correlated directly with increasing agonist efficacy: maximal changes were seen following chronic treatment with diazepam, intermediate changes were seen following the partial agonist Ro 16–6028 and no changes were observed following chronic Ro 15–1788 administration. The magnitude of change could also be correlated with increasing potential for tolerance development to anticonvulsant efficacy following chronic exposure to these benzodiazepine ligands.
doi_str_mv 10.1016/0014-2999(89)90535-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79464780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299989905359</els_id><sourcerecordid>79464780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-39f258fcb589f77f2041691299d1030dd067023f1272336b39ad74c5287e8a5e3</originalsourceid><addsrcrecordid>eNqFkcGKFDEQhhtR1nH1DRRyENFDa5LudDoXYVx0FRYE0XPIpCuzJZmkTbpHZ9_BdzbtDHPUQ0igvvqp1FdVTxl9zSjr3lDK2porpV726pWiohG1uletWC9VTSXj96vVGXlYPcr5O6VUKC4uqgsumFCyW1W_v4A3E8aQb3Ek0RGzjQHzRMA5tMYeyBSJvTVhC5lgINfrd2uSIWSccI_TgZgwlDOhjWE_-1yepcNDMsECcdH7-BPDtkSkkmvJBsJdHNDcwYgBiMftEgC_xpjnBI-rB874DE9O92X17cP7r1cf65vP15-u1je1bftmqhvluOid3YheOSkdpy3rFCsfHRht6DDQTlLeOMYlb5pu0ygzyNYK3kvojYDmsnpxzB1T_DFDnvQOswXvTYA4Zy1V27Wyp_8FmWhFJ6QqYHsEbYo5J3B6TLgz6aAZ1YsuvbjQiwvdK_1Xl17anp3y580OhnPTyU-pPz_VTbbGu2WtmM9Y13GpZFuwt0cMytL2CElni1AMDJjATnqI-O85_gBb_LMO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15456579</pqid></control><display><type>article</type><title>Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hernandez, Theresa D. ; Heninger, Catherine ; Wilson, Marlene A. ; Gallager, Dorothy W.</creator><creatorcontrib>Hernandez, Theresa D. ; Heninger, Catherine ; Wilson, Marlene A. ; Gallager, Dorothy W.</creatorcontrib><description>Benzodiazepine ligands of differing efficacy including the agonist, diazepam, the partial agonist, Ro 16–6028 and the antagonist, Ro 15–1788, were administered in vivo to rats continuously for 3 weeks. The magnitude of change in various measures of GABA sensitivity could be correlated directly with increasing agonist efficacy: maximal changes were seen following chronic treatment with diazepam, intermediate changes were seen following the partial agonist Ro 16–6028 and no changes were observed following chronic Ro 15–1788 administration. The magnitude of change could also be correlated with increasing potential for tolerance development to anticonvulsant efficacy following chronic exposure to these benzodiazepine ligands.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(89)90535-9</identifier><identifier>PMID: 2515976</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Agonist efficacy ; Animals ; Anticonvulsants ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Behavior, Animal - drug effects ; Benzodiazepines (chronic) ; Benzodiazepines - pharmacology ; Benzodiazepinones - pharmacology ; Bicuculline - metabolism ; Bicuculline - pharmacology ; Biological and medical sciences ; Brain Chemistry - drug effects ; Diazepam - pharmacology ; Drug Tolerance ; Electrophysiology ; Flumazenil - pharmacology ; GABA ; gamma-Aminobutyric Acid - physiology ; Male ; Medical sciences ; Neuropharmacology ; Pharmacology. Drug treatments ; Raphe Nuclei - drug effects ; Raphe Nuclei - physiology ; Rats ; Rats, Inbred Strains ; Seizures - physiopathology ; Tolerance</subject><ispartof>European journal of pharmacology, 1989-11, Vol.170 (3), p.145-155</ispartof><rights>1989</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-39f258fcb589f77f2041691299d1030dd067023f1272336b39ad74c5287e8a5e3</citedby><cites>FETCH-LOGICAL-c483t-39f258fcb589f77f2041691299d1030dd067023f1272336b39ad74c5287e8a5e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0014299989905359$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6627974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2515976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernandez, Theresa D.</creatorcontrib><creatorcontrib>Heninger, Catherine</creatorcontrib><creatorcontrib>Wilson, Marlene A.</creatorcontrib><creatorcontrib>Gallager, Dorothy W.</creatorcontrib><title>Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Benzodiazepine ligands of differing efficacy including the agonist, diazepam, the partial agonist, Ro 16–6028 and the antagonist, Ro 15–1788, were administered in vivo to rats continuously for 3 weeks. The magnitude of change in various measures of GABA sensitivity could be correlated directly with increasing agonist efficacy: maximal changes were seen following chronic treatment with diazepam, intermediate changes were seen following the partial agonist Ro 16–6028 and no changes were observed following chronic Ro 15–1788 administration. The magnitude of change could also be correlated with increasing potential for tolerance development to anticonvulsant efficacy following chronic exposure to these benzodiazepine ligands.</description><subject>Agonist efficacy</subject><subject>Animals</subject><subject>Anticonvulsants</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Behavior, Animal - drug effects</subject><subject>Benzodiazepines (chronic)</subject><subject>Benzodiazepines - pharmacology</subject><subject>Benzodiazepinones - pharmacology</subject><subject>Bicuculline - metabolism</subject><subject>Bicuculline - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Brain Chemistry - drug effects</subject><subject>Diazepam - pharmacology</subject><subject>Drug Tolerance</subject><subject>Electrophysiology</subject><subject>Flumazenil - pharmacology</subject><subject>GABA</subject><subject>gamma-Aminobutyric Acid - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Raphe Nuclei - drug effects</subject><subject>Raphe Nuclei - physiology</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Seizures - physiopathology</subject><subject>Tolerance</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcGKFDEQhhtR1nH1DRRyENFDa5LudDoXYVx0FRYE0XPIpCuzJZmkTbpHZ9_BdzbtDHPUQ0igvvqp1FdVTxl9zSjr3lDK2porpV726pWiohG1uletWC9VTSXj96vVGXlYPcr5O6VUKC4uqgsumFCyW1W_v4A3E8aQb3Ek0RGzjQHzRMA5tMYeyBSJvTVhC5lgINfrd2uSIWSccI_TgZgwlDOhjWE_-1yepcNDMsECcdH7-BPDtkSkkmvJBsJdHNDcwYgBiMftEgC_xpjnBI-rB874DE9O92X17cP7r1cf65vP15-u1je1bftmqhvluOid3YheOSkdpy3rFCsfHRht6DDQTlLeOMYlb5pu0ygzyNYK3kvojYDmsnpxzB1T_DFDnvQOswXvTYA4Zy1V27Wyp_8FmWhFJ6QqYHsEbYo5J3B6TLgz6aAZ1YsuvbjQiwvdK_1Xl17anp3y580OhnPTyU-pPz_VTbbGu2WtmM9Y13GpZFuwt0cMytL2CElni1AMDJjATnqI-O85_gBb_LMO</recordid><startdate>19891107</startdate><enddate>19891107</enddate><creator>Hernandez, Theresa D.</creator><creator>Heninger, Catherine</creator><creator>Wilson, Marlene A.</creator><creator>Gallager, Dorothy W.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19891107</creationdate><title>Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure</title><author>Hernandez, Theresa D. ; Heninger, Catherine ; Wilson, Marlene A. ; Gallager, Dorothy W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-39f258fcb589f77f2041691299d1030dd067023f1272336b39ad74c5287e8a5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Agonist efficacy</topic><topic>Animals</topic><topic>Anticonvulsants</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Behavior, Animal - drug effects</topic><topic>Benzodiazepines (chronic)</topic><topic>Benzodiazepines - pharmacology</topic><topic>Benzodiazepinones - pharmacology</topic><topic>Bicuculline - metabolism</topic><topic>Bicuculline - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Brain Chemistry - drug effects</topic><topic>Diazepam - pharmacology</topic><topic>Drug Tolerance</topic><topic>Electrophysiology</topic><topic>Flumazenil - pharmacology</topic><topic>GABA</topic><topic>gamma-Aminobutyric Acid - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Raphe Nuclei - drug effects</topic><topic>Raphe Nuclei - physiology</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Seizures - physiopathology</topic><topic>Tolerance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernandez, Theresa D.</creatorcontrib><creatorcontrib>Heninger, Catherine</creatorcontrib><creatorcontrib>Wilson, Marlene A.</creatorcontrib><creatorcontrib>Gallager, Dorothy W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernandez, Theresa D.</au><au>Heninger, Catherine</au><au>Wilson, Marlene A.</au><au>Gallager, Dorothy W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1989-11-07</date><risdate>1989</risdate><volume>170</volume><issue>3</issue><spage>145</spage><epage>155</epage><pages>145-155</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Benzodiazepine ligands of differing efficacy including the agonist, diazepam, the partial agonist, Ro 16–6028 and the antagonist, Ro 15–1788, were administered in vivo to rats continuously for 3 weeks. The magnitude of change in various measures of GABA sensitivity could be correlated directly with increasing agonist efficacy: maximal changes were seen following chronic treatment with diazepam, intermediate changes were seen following the partial agonist Ro 16–6028 and no changes were observed following chronic Ro 15–1788 administration. The magnitude of change could also be correlated with increasing potential for tolerance development to anticonvulsant efficacy following chronic exposure to these benzodiazepine ligands.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>2515976</pmid><doi>10.1016/0014-2999(89)90535-9</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1989-11, Vol.170 (3), p.145-155
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_79464780
source MEDLINE; Elsevier ScienceDirect Journals
subjects Agonist efficacy
Animals
Anticonvulsants
Anticonvulsants. Antiepileptics. Antiparkinson agents
Behavior, Animal - drug effects
Benzodiazepines (chronic)
Benzodiazepines - pharmacology
Benzodiazepinones - pharmacology
Bicuculline - metabolism
Bicuculline - pharmacology
Biological and medical sciences
Brain Chemistry - drug effects
Diazepam - pharmacology
Drug Tolerance
Electrophysiology
Flumazenil - pharmacology
GABA
gamma-Aminobutyric Acid - physiology
Male
Medical sciences
Neuropharmacology
Pharmacology. Drug treatments
Raphe Nuclei - drug effects
Raphe Nuclei - physiology
Rats
Rats, Inbred Strains
Seizures - physiopathology
Tolerance
title Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A46%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20of%20agonist%20efficacy%20to%20changes%20in%20GABA%20sensitivity%20and%20anticonvulsant%20tolerance%20following%20chronic%20benzodiazepine%20ligand%20exposure&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Hernandez,%20Theresa%20D.&rft.date=1989-11-07&rft.volume=170&rft.issue=3&rft.spage=145&rft.epage=155&rft.pages=145-155&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/0014-2999(89)90535-9&rft_dat=%3Cproquest_cross%3E79464780%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15456579&rft_id=info:pmid/2515976&rft_els_id=0014299989905359&rfr_iscdi=true